Product
DA-EPOCH-R
1 clinical trial
6 indications
Indication
Non-Hodgkin LymphomaIndication
lymphomaIndication
B-cellIndication
High-grade B-cell lymphomaIndication
MYC TranslocationIndication
BCL-2 TranslocationClinical trial
A Phase II Study Evaluating the Effect of DA-EPOCH-R Induction Followed by Nivolumab Consolidation in Patients With Newly Diagnosed High Grade B Cell Lymphoma (HGBL) With MYC and BCL2 and/or BCL6 RearrangementsStatus: Active (not recruiting), Estimated PCD: 2024-01-30